AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Burning Rock Biotech Limited
Video analysis: BNR
All videosNo video analysis for this stock yet. Request one from our team.
News: BNR
Burning Rock Reports Second Quarter 2026 Financial Results
GUANGZHOU, China, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended June 30, 2026.
Burning Rock Announces Founder's Purchase of Its ADSs
GUANGZHOU, China, July 02, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that its founder, chairman of the board of directors and chief executive officer, Mr. Yusheng Han, has purchased 73,141 of the Company's ADSs for US$618,217.72 from the open market, which was conducted in compliance with the applicable rules and regulations and the Company's insider trading policy.
Similar companies
-
American Shared Hospital Services
AMS
·
New York Stock Exchange Arca
Compare
-
ProMIS Neurosciences, Inc.
PMN
·
NASDAQ
Compare
-
ProPhase Labs, Inc.
PRPH
·
Other OTC
Compare
-
Co-Diagnostics, Inc.
CODX
·
NASDAQ
Compare
-
Aytu BioPharma, Inc.
AYTU
·
NASDAQ
Compare
-
enVVeno Medical Corporation
NVNO
·
NASDAQ
Compare